Patents/Assignees

CAYMAN CHEMICAL COMPANY, Inc.

1 patent in portfolio

US11884624utility2024
Difluorolactam Compounds as EP4 Receptor-selective Agonists for Use in the Treatment of Ep4-mediated Diseases and Conditions
0 cites